In other studies of stroke [52], JAM-A, ZO-1, and claudin-5 were found not to correlate with blood-brain barrier breakdown in the acute phase; however, a decrease in claudin-5 levels may indicate improved barrier function by 10 days. This evidence concerns the gene CLDN5 and Stroke.